Lab profile
About CIMBID
CIMBID focuses on leveraging artificial intelligence approaches with cutting-edge biomedical imaging technologies and multi-modal biomarkers to transform personalized medicine. The center's research spans from developing core computational methodologies in AI and biomedical image analysis to discovering and validating biomarkers across disease domains including cancer, neuroscience, and chronic illnesses, aiming to generate mechanistic insights and practical tools for personalized clinical decision-making in disease prevention, diagnosis, and treatment.
01 · Research focus
Research areas and highlights
Topics and recent work as stated on the lab’s own site.
- AI-Enabled Multimodal Neuroimaging Biomarkers of Brain Dynamics and Subcortical Structures in Depression and StrokeDeveloping sensitive and individualized neuroimaging biomarkers for depression and stroke using brain criticality theory and subcortical structural abnormalities combined with explainable AI models.
- Early Prediction of Neoadjuvant Chemotherapy Response Using Quantitative Harmonic Motion Imaging BiomarkersUsing Harmonic Motion Imaging ultrasound elastography to quantify tumor stiffness changes to predict pathologic complete response and identify regions of drug resistance in breast cancer patients.
- Incidence and Characterization of Lung Nodules in AATDCombining expert radiology reads with quantitative CT and AI tools to build an AATD-specific risk prediction approach for lung nodule assessment in alpha-1 antitrypsin deficiency patients.
02 · People
Leadership and researchers
People listed on the lab’s team pages, by role.
03 · Research intelligence
Research Intelligence evidence
Publications, grants and clinical trials linked to the lab’s researchers in Health AI Central’s research data.
Publications & preprints
- Publisher Correction: Sleep chart of biological ageing clocks in middle and late life.Nature · 2026
- Correction to: Multi-center evaluation of radiomics and deep learning to stratify malignancy risk of IPMNs.Abdominal radiology (New York) · 2026
- Sex-specific biological aging clocks across organs and omics.Nature medicine · 2026
Active NIH grants
- Clinical and Translational Science Award (CTSA) UM1 at Columbia UniversityMuredach Patrick Reilly · NCATS · FY 2026
- Precision quantification of diurnal activity to promote cognitive healthJeff Goldsmith · NIA · FY 2026
- Cardiopulmonary Failure in COPD and HFpEF: SPIROMICS HF2R Graham Barr · NHLBI · FY 2026
Clinical-trial records
- Cardiac Amyloidosis Discovery TrialNCT06469372 · Completed
04 · Updates
Updates and lab news
News and events from the lab’s own site.
- Despina Kontos Selected as 2026 Breast Cancer Research Foundation InvestigatorAwardOct 16, 2026 · columbiaradiology.org
- CIMBID and Columbia Data Science Institute Launch New Biomedical Imaging Data Science ProgramAnnouncementJul 29, 2026 · vagelos.columbia.edu
- Too Little Sleep—and Too Much—Associated with Faster AgingNewsJul 22, 2026 · cuimc.columbia.edu
- NIH Grant Supports Research to Improve Prediction of Advanced Breast Cancer RiskNewsJun 24, 2026 · columbiaradiology.org
- New Study Aims to Predict Susceptibility to Alzheimer's DiseaseNewsAug 29, 2025 · columbiaradiology.org
- Columbia Launches the Center for Innovation in Imaging Biomarkers and Integrated Diagnostics (CIMBID)AnnouncementJun 24, 2025 · columbiaradiology.org
- Neuroimaging Endophenotypes Reveal Underlying Mechanisms and Genetic Factors Contributing to Progression and Development of Four Brain DisordersPublicationJun 6, 2025 · nature.com
- Breast Textures Seen on Mammograms Linked to Cancer RiskNewsMay 13, 2025 · cuimc.columbia.edu
05 · Official presence
Lab sources and channels
The lab’s own pages and accounts.
06 · Related
Related labs and centers
Labs at the same institution and labs working on similar topics.